BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 26526971)

  • 21. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
    Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
    Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early add-on lacosamide in a real-life setting: results of the REALLY study.
    Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
    Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
    Ben-Menachem E; Biton V; Jatuzis D; Abou-Khalil B; Doty P; Rudd GD
    Epilepsia; 2007 Jul; 48(7):1308-17. PubMed ID: 17635557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
    Hong Z; Inoue Y; Liao W; Meng H; Wang X; Wang W; Zhou L; Zhang L; Du X; Tennigkeit F;
    Epilepsy Res; 2016 Nov; 127():267-275. PubMed ID: 27669155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
    Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
    Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
    Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
    Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
    Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
    Kissin MY; Bondarenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
    Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
    Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
    Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.